Redeye: AVTECH - Strong FX Tailwinds
AVTECH’s Q3 beat our expectations on EBITDA while being in line in terms of revenue. The main drivers were strong FX and lower-than-expected personnel costs. We have made no estimate changes and expect new contracts in 2023. Our Fair Value Range remains at SEK1.2 to 7.2, and our Base Case remains at SEK3.6.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking.